These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23919297)

  • 61. Enteroviruses, type 1 diabetes and hygiene: a complex relationship.
    Tracy S; Drescher KM; Jackson JD; Kim K; Kono K
    Rev Med Virol; 2010 Mar; 20(2):106-16. PubMed ID: 20049905
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Viruses Run: The Evasion Mechanisms of the Antiviral Innate Immunity by Hantavirus.
    Zhang Y; Ma R; Wang Y; Sun W; Yang Z; Han M; Han T; Wu XA; Liu R
    Front Microbiol; 2021; 12():759198. PubMed ID: 34659193
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multifunctionality of structural proteins in the enterovirus life cycle.
    Wen X; Sun D; Guo J; Elgner F; Wang M; Hildt E; Cheng A
    Future Microbiol; 2019 Sep; 14():1147-1157. PubMed ID: 31368347
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Host Restrictive Factors Are the Emerging Storm Troopers Against Enterovirus: A Mini-Review.
    Huan C; Qu X; Li Z
    Front Immunol; 2022; 13():910780. PubMed ID: 35603180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent Developments.
    Schulz KS; Mossman KL
    Front Immunol; 2016; 7():498. PubMed ID: 27891131
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA and Pathogenesis of Enterovirus Infection.
    Ho BC; Yang PC; Yu SL
    Viruses; 2016 Jan; 8(1):. PubMed ID: 26751468
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Interplay Between Coronavirus and Type I IFN Response.
    Xue W; Ding C; Qian K; Liao Y
    Front Microbiol; 2021; 12():805472. PubMed ID: 35317429
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immune Evasion of Enteroviruses Under Innate Immune Monitoring.
    Zhang Y; Li J; Li Q
    Front Microbiol; 2018; 9():1866. PubMed ID: 30154774
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gemcitabine, a broad-spectrum antiviral drug, suppresses enterovirus infections through innate immunity induced by the inhibition of pyrimidine biosynthesis and nucleotide depletion.
    Lee K; Kim DE; Jang KS; Kim SJ; Cho S; Kim C
    Oncotarget; 2017 Dec; 8(70):115315-115325. PubMed ID: 29383162
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of type I interferon signaling by natural products in the treatment of immune-related diseases.
    Li S; Fan G; Li X; Cai Y; Liu R
    Chin J Nat Med; 2023 Jan; 21(1):3-18. PubMed ID: 36641230
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulation of Apoptosis by Enteroviruses.
    Lai Y; Wang M; Cheng A; Mao S; Ou X; Yang Q; Wu Y; Jia R; Liu M; Zhu D; Chen S; Zhang S; Zhao XX; Huang J; Gao Q; Wang Y; Xu Z; Chen Z; Zhu L; Luo Q; Liu Y; Yu Y; Zhang L; Tian B; Pan L; Rehman MU; Chen X
    Front Microbiol; 2020; 11():1145. PubMed ID: 32582091
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fine-tuning type I IFN signaling: A new chapter in the IFN saga.
    Yanai H; Taniguchi T
    Cell Res; 2017 Dec; 27(12):1407-1408. PubMed ID: 28925385
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enteric viruses seize their immunomodulatory niche.
    Campbell DE; Baldridge MT
    Cell Host Microbe; 2021 Jun; 29(6):858-861. PubMed ID: 34111394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enterovirus infections: Pivoting role of the adaptive immune response.
    Bopegamage S
    Virulence; 2016 Jul; 7(5):495-7. PubMed ID: 27058267
    [No Abstract]   [Full Text] [Related]  

  • 75. Anti-chicken type I IFN countermeasures by major avian RNA viruses.
    Anjum FR; Anam S; Rahman SU; Ali S; Aslam MA; Rizvi F; Asif M; Abdullah RM; Abaidullah M; Shakir MZ; Goraya MU
    Virus Res; 2020 Sep; 286():198061. PubMed ID: 32561378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A mouse model and pathogenesis study for CVA19 first isolated from hand, foot, and mouth disease.
    Ji W; Tao L; Li D; Zhu P; Wang Y; Zhang Y; Zhang L; Chen S; Yang H; Jin Y; Duan G
    Emerg Microbes Infect; 2023 Dec; 12(1):2177084. PubMed ID: 36735880
    [No Abstract]   [Full Text] [Related]  

  • 77. IFN-β1b induces OAS3 to inhibit EV71 via IFN-β1b/JAK/STAT1 pathway.
    Zheng B; Zhou X; Tian L; Wang J; Zhang W
    Virol Sin; 2022 Oct; 37(5):676-684. PubMed ID: 35934228
    [TBL] [Abstract][Full Text] [Related]  

  • 78. EV71 3C protease cleaves host anti-viral factor OAS3 and enhances virus replication.
    Zhou X; Tian L; Wang J; Zheng B; Zhang W
    Virol Sin; 2022 Jun; 37(3):418-426. PubMed ID: 35504537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coxsackievirus Type B3 Is a Potent Oncolytic Virus against
    Deng H; Liu H; de Silva T; Xue Y; Mohamud Y; Ng CS; Qu J; Zhang J; Jia WWG; Lockwood WW; Luo H
    Mol Ther Oncolytics; 2019 Sep; 14():266-278. PubMed ID: 31463367
    [No Abstract]   [Full Text] [Related]  

  • 80. Influence of Nonpolio Enteroviruses and the Bacterial Gut Microbiota on Oral Poliovirus Vaccine Response: A Study from South India.
    Praharaj I; Parker EPK; Giri S; Allen DJ; Silas S; Revathi R; Kaliappan SP; John J; Prasad JH; Kampmann B; Iturriza-Gómara M; Grassly NC; Kang G
    J Infect Dis; 2019 Apr; 219(8):1178-1186. PubMed ID: 30247561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.